Source:http://linkedlifedata.com/resource/pubmed/id/19295477
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-10-22
|
pubmed:abstractText |
We have recently found that suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, improves survival in a lethal model of hemorrhagic shock in rats. The purpose of the present study was to determine whether SAHA treatment would prevent LPS-induced septic shock and improve the survival in a murine model. C57BL/6J mice were randomly divided into two groups. Experimental mice were given intraperitoneal SAHA (50 mg/kg) in vehicle dimethyl sulfoxide fluid (n = 10). The control mice (n = 10) received vehicle dimethyl sulfoxide only. They were injected with LPS (20 mg/kg, i.p.) 2 h later, and the animals from the treatment group were given a second dose of SAHA. Survival was monitored during the next 7 days. In a parallel study, mice treated with or without SAHA were subjected to LPS insult while normal (sham) mice serviced as controls. 1) Lungs were harvested at 3 and 48 h for analysis of gene expression and pathologic changes, respectively; 2) spleens were isolated for analysis of neutrophilic cell population. In addition, RAW264.7 mouse macrophages were cultured to assess the effects of SAHA on LPS-induced inflammation in vitro. All mice in the control group that were subjected to LPS challenge died in less than 48 h. However, SAHA-treated animals displayed a significantly higher 1-week survival rate (87.5%) compared with the control group (0%). Moreover, LPS insult decreased the acetylation of histone proteins (H2A, H2B, and H3), elevated the levels of TNF-alpha in vivo (circulation) and in vitro (culture medium), increased the neutrophilic cell population in the spleen, enhanced the expression of TNF-alpha and IL-1beta genes in lung tissue, and augmented the pulmonary neutrophil infiltration. In contrast, SAHA treatment markedly attenuated all of these LPS-induced alterations. We report for the first time that administration of SAHA (50 mg/kg) significantly attenuates a variety of inflammatory markers and improves long-term survival after a lethal LPS insult.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Histone Deacetylase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Histones,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1beta,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Peroxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/vorinostat
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1540-0514
|
pubmed:author |
pubmed-author:AlamHasan BHB,
pubmed-author:FinkelsteinRobert ARA,
pubmed-author:FukudomeEugene YEY,
pubmed-author:HalesCharles ACA,
pubmed-author:KheirbekTareqT,
pubmed-author:LiYongqingY,
pubmed-author:LiuBaolingB,
pubmed-author:SailhamerElizabeth AEA,
pubmed-author:VelmahosGeorge CGC,
pubmed-author:ZhangXiaoboX,
pubmed-author:ZhaoHangH,
pubmed-author:deMoyaMarcM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
517-23
|
pubmed:dateRevised |
2011-2-1
|
pubmed:meshHeading |
pubmed-meshheading:19295477-Acetylation,
pubmed-meshheading:19295477-Acute Lung Injury,
pubmed-meshheading:19295477-Animals,
pubmed-meshheading:19295477-Blotting, Western,
pubmed-meshheading:19295477-Cell Line, Tumor,
pubmed-meshheading:19295477-Flow Cytometry,
pubmed-meshheading:19295477-Histone Deacetylase Inhibitors,
pubmed-meshheading:19295477-Histones,
pubmed-meshheading:19295477-Hydroxamic Acids,
pubmed-meshheading:19295477-Interleukin-1beta,
pubmed-meshheading:19295477-Lipopolysaccharides,
pubmed-meshheading:19295477-Male,
pubmed-meshheading:19295477-Mice,
pubmed-meshheading:19295477-Mice, Inbred C57BL,
pubmed-meshheading:19295477-Peroxidase,
pubmed-meshheading:19295477-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19295477-Shock, Septic,
pubmed-meshheading:19295477-Tumor Necrosis Factor-alpha
|
pubmed:year |
2009
|
pubmed:articleTitle |
Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents.
|
pubmed:affiliation |
Department of Surgery, Division of Trauma, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts 02114, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|